0001447362-20-000101.txt : 20200604
0001447362-20-000101.hdr.sgml : 20200604
20200604160726
ACCESSION NUMBER: 0001447362-20-000101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200602
FILED AS OF DATE: 20200604
DATE AS OF CHANGE: 20200604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spiess Bernhard E.
CENTRAL INDEX KEY: 0001782994
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38984
FILM NUMBER: 20943005
MAIL ADDRESS:
STREET 1: C/O CASTLE BIOSCIENCES, INC.
STREET 2: 820 S. FRIENDSWOOD DRIVE, SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC
CENTRAL INDEX KEY: 0001447362
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770701744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 820 S FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
BUSINESS PHONE: 866-788-9007
MAIL ADDRESS:
STREET 1: 820 S FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
4
1
wf-form4_159130122788334.xml
FORM 4
X0306
4
2020-06-02
0
0001447362
CASTLE BIOSCIENCES INC
CSTL
0001782994
Spiess Bernhard E.
C/O CASTLE BIOSCIENCES, INC.
820 S. FRIENDSWOOD DRIVE, STE. 201
FRIENDSWOOD
TX
77546
0
1
0
0
Chief Business Officer
Common Stock
2020-06-02
4
S
0
31833
38.18
D
126026
D
Common Stock
2020-06-02
4
S
0
400
38.94
D
125626
D
This transaction was executed in multiple trades at prices ranging from $37.93 to $38.92, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $38.93 to $38.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Greg Acosta, Attorney-in-fact
2020-06-04